Triple Agonist
GLP-1/GIP/Glucagon
₱1700.00
Retatrutide is an investigational glucose-dependent insulinotropic polypeptide (GIP) receptor, glucagon-like peptide-1 (GLP-1) receptor, and glucagon (GR) receptor agonist indicated in combination with a reduced-calorie diet and increased physical activity:
• to reduce excess body weight and maintain weight reduction long term in adults with obesity or adults with overweight in the presence of at least one weight-related comorbid condition.